- Home
- KRMD vs SCPH Comparison
KRMD vs SCPH Comparison
Compare KRMD & SCPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- SCPH
- Stock Information
- Founded
- KRMD 1980
- SCPH 2013
- Country
- KRMD United States
- SCPH United States
- Employees
- KRMD N/A
- SCPH N/A
- Industry
- KRMD Medical/Dental Instruments
- SCPH Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- SCPH Health Care
- Exchange
- KRMD Nasdaq
- SCPH Nasdaq
- Market Cap
- KRMD 134.3M
- SCPH 299.0M
- IPO Year
- KRMD N/A
- SCPH 2017
- Fundamental
- Price
- KRMD $3.96
- SCPH $5.63
- Analyst Decision
- KRMD Strong Buy
- SCPH Buy
- Analyst Count
- KRMD 4
- SCPH 3
- Target Price
- KRMD $4.63
- SCPH $12.00
- AVG Volume (30 Days)
- KRMD 63.4K
- SCPH 2.4M
- Earning Date
- KRMD 11-12-2025
- SCPH 11-12-2025
- Dividend Yield
- KRMD N/A
- SCPH N/A
- EPS Growth
- KRMD N/A
- SCPH N/A
- EPS
- KRMD N/A
- SCPH N/A
- Revenue
- KRMD $36,848,451.00
- SCPH $49,969,000.00
- Revenue This Year
- KRMD $21.08
- SCPH $104.30
- Revenue Next Year
- KRMD $16.37
- SCPH $76.06
- P/E Ratio
- KRMD N/A
- SCPH N/A
- Revenue Growth
- KRMD 19.57
- SCPH 107.79
- 52 Week Low
- KRMD $1.86
- SCPH $1.94
- 52 Week High
- KRMD $5.05
- SCPH $6.28
- Technical
- Relative Strength Index (RSI)
- KRMD 48.23
- SCPH 63.97
- Support Level
- KRMD $3.87
- SCPH $4.33
- Resistance Level
- KRMD $4.12
- SCPH $5.62
- Average True Range (ATR)
- KRMD 0.13
- SCPH 0.04
- MACD
- KRMD -0.04
- SCPH -0.01
- Stochastic Oscillator
- KRMD 20.37
- SCPH 86.67
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About SCPH scPharmaceuticals Inc.
scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs. The company's main product is Furoscix to treat congestion in patients with heart failure and edema in patients with chronic kidney disease. Furoscix is a novel formulation of furosemide contained in a pre-filled, Crystal Zenith cartridge and self-administered subcutaneously via a single-use, disposable, and wearable on-body delivery system.